Home 2021 Simple Way to Stop and Reverse Brain Aging

Simple Way to Stop and Reverse Brain Aging

by Paul Ebeling

#brain #aging

The architecture of the human brain is designed to run on 1 fuel, glucose“– Paul Ebeling

The bad news about PUFA aka polyunsaturated fats, has been accumulating for decades, but public health authorities continue to claim that type of fat is “essential”.

Whatever indirect admissions of the pathological role of PUFA in both chronic and acute/infectious diseases is given to the public, is usually confined to the well-known PUFA metabolites known as prostaglandins.

The disclaimer is always that even if prostaglandins have known pathological effects, those effects are limited to acute inflammatory reactions and some of those are even claimed to be beneficial.

Well, according to the study below, the prostaglandins are perhaps the primary driver of brain aging and the pathological effects they exert is due to lowering the metabolic rate of brain cells by restricting glucose metabolism.

So, by blocking the effects of prostaglandins the glucose metabolism is restored, reversed the metabolic rate inhibition, and reversed the aging brain phenotype.

In Summary

For those that still defend PUFA or think it is essential; according to the study below, PUFA is a direct causative factor in brain aging trough increased inflammation and decreased metabolic rate carried out by its metabolites known as prostaglandins.

Blocking the effects prostaglandins or restricting dietary PUFA, can fully reverse brain aging.

So, what I did when I learned this some time ago is: cut out corn, flaxseed (Canola) soybean and safflower oils in my diet. Good olive oil is my alternative, though expensive is it not as expensive as Rx drugs.

The study used a selective prostaglandin antagonist, which is far from optimal since it acts way downstream and will miss any other “non-genomic” (non-receptor-mediated) negative effects prostaglandins have.

It would be preferable to administer the well-known and battle-tested COX inhibitors, which inhibit the very synthesis of prostaglandins.

You are right the preferred COX inhibitor will be aspirin.

Yes, aspirin has already had numerous observational human studies strongly suggesting it has pro-cognitive and anti-aging effects in the human brain.

Animal studies go much further and have already demonstrated that aspirin can cure Alzheimer disease (AD) in rodents, as well as extend maximum lifespan of yeast/worms by more than 400%.

The new study now provides a solid justification/rationale for those well-documented beneficial effects of aspirin on the nervous system.

Lastly, if prostaglandins are the primary driver of impaired glucose metabolism the findings of the study below suggest that aspirin would be a great intervention for conditions such as the metabolic syndrome and diabetes II.

There is 1 study with already diabetic humans demonstrating that a high dose aspirin completely reversed their glucose metabolism abnormalities, so considering the new study I do not see a good reason why medicine refuses to try aspirin as treatment for all such conditions.

The Stanford Study

Eat healthy, Be healthy, Live lively

You may also like

logo-white

Your Trusted Source for Capital Markets & Related News

© 2024 LiveTradingNews.com – For The Traders, By The Traders – All Right Reserved.

The information contained on this website shall not be construed as (i) an offer to purchase or sell, or the solicitation of an offer to purchase or sell, any securities or services, (ii) investment, legal, business or tax advice or an offer to provide such advice, or (iii) a basis for making any investment decision. An offering may only be made upon a qualified investor’s receipt not via this website of formal materials from the Knightsbridge an offering memorandum and subscription documentation (“offering materials”). In the case of any inconsistency between the information on this website and any such offering materials, the offering materials shall control. Securities shall not be offered or sold in any jurisdiction in which such offer or sale would be unlawful unless the requirements of the applicable laws of such jurisdiction have been satisfied. Any decision to invest in securities must be based solely upon the information set forth in the applicable offering materials, which should be read carefully by qualified investors prior to investing. An investment with Knightsbridge is not suitable or desirable for all investors; investors may lose all or a portion of the capital invested. Investors may be required to bear the financial risks of an investment for an indefinite period of time. Qualified investors are urged to consult with their own legal, financial and tax advisors before making any investment. Knightsbridge is a private investment firm that offers investment services to Qualified Investors, Members and Institutions ONLY. Qualified Investors are defined as individuals who have met those Qualifications in the relevant jurisdictions. Members are defined as individuals who have been accepted into the Knightsbridge membership program. Institutions are defined as entities such as banks, pension funds, and hedge funds. If you are not a Qualified Investor, Member or Institution, you are not eligible to invest with Knightsbridge. All investments involve risk, and there is no guarantee of profit. You may lose some or all of your investment. Past performance is not indicative of future results. Knightsbridge is not a registered investment advisor, and this disclaimer should not be construed as investment advice. Please consult with a qualified financial advisor before making any investment decisions. By accessing this website, you agree to the terms of this disclaimer. Thank you for your interest in Knightsbridge.